Survival benefit from response-guided approach: a direct effect of more effective cytotoxic regimens or an indirect effect of chemotherapy-induced amenorrhea? Reply to K.-D. Yu et al

Affiliations

Comment

Gunter von Minckwitz et al. J Clin Oncol. 2014.

. 2014 Apr 20;32(12):1283-4.

doi: 10.1200/JCO.2013.54.4437. Epub 2014 Mar 17.

¹ German Breast Group, Neu-Isenburg; University Hospital Frankfurt, Frankfurt, Germany.

No abstract available

Comment on

Response-guided neoadjuvant chemotherapy for breast cancer.
von Minckwitz G, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Eiermann W, Gerber B, Hanusch C, Hilfrich J, Huober J, Jackisch C, Kaufmann M, Kümmel S, Paepke S, Schneeweiss A, Untch M, Zahm DM, Mehta K, Loibl S. von Minckwitz G, et al. J Clin Oncol. 2013 Oct 10;31(29):3623-30. doi: 10.1200/JCO.2012.45.0940. Epub 2013 Sep 3. J Clin Oncol. 2013. PMID: 24002511 Clinical Trial.
Survival benefit from response-guided approach: a direct effect of more effective cytotoxic regimens or an indirect effect of chemotherapy-induced amenorrhea?
Yu KD, Shao ZM. Yu KD, et al. J Clin Oncol. 2014 Apr 20;32(12):1282-3. doi: 10.1200/JCO.2013.53.7555. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24638014 No abstract available.